Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system

被引:24
|
作者
Takei, Hiroaki [1 ,2 ,4 ]
Shinoda, Jun [1 ,2 ,3 ]
Ikuta, Soko [5 ]
Maruyama, Takashi [5 ]
Muragaki, Yoshihiro [5 ]
Kawasaki, Tomohiro [1 ,2 ,4 ]
Ikegame, Yuka [1 ,2 ,3 ]
Okada, Makoto [1 ,2 ]
Ito, Takeshi [1 ,2 ]
Asano, Yoshitaka [1 ,2 ,3 ]
Yokoyama, Kazutoshi [1 ,2 ]
Nakayama, Noriyuki [4 ]
Yano, Hirohito [4 ]
Iwama, Toru [4 ]
机构
[1] Kizawa Mem Hosp, Dept Neurosurg, Minokamo, Gifu, Japan
[2] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu, Japan
[3] Gifu Univ, Grad Sch Med, Dept Clin Brain Sci, Gifu, Japan
[4] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan
[5] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan
基金
日本学术振兴会;
关键词
C-11-methionine; C-11-choline; F-18-fluorodeoxyglucose; positron emission tomography; glioma; isocitrate dehydrogenase mutation; oncology; C-11-METHIONINE PET; C-11; METHIONINE; IDH2; MUTATIONS; BRAIN-TUMORS; F-18-FDG PET; SURVIVAL; C-11-CHOLINE; DIAGNOSIS; NECROSIS; CHOLINE;
D O I
10.3171/2019.5.JNS19780
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: Positron emission tomography (PET) is important in the noninvasive diagnostic imaging of gliomas. There are many PET studies on glioma diagnosis based on the 2007 WHO classification; however, there are no studies on glioma diagnosis using the new classification (the 2016 WHO classification). Here, the authors investigated the relationship between uptake of 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG) on PET imaging and isocitrate dehydrogenase (IDH) status (wild-type [IDH-wt] or mutant [IDH-mut]) in astrocytic and oligodendroglial tumors according to the 2016 WHO classification. METHODS: In total, 105 patients with newly diagnosed cerebral gliomas (6 diffuse astrocytomas [DAs] with IDH-wt, 6 DAs with IDH-mut, 7 anaplastic astrocytomas [AAs] with IDH-wt, 24 AAs with IDH-mut, 26 glioblastomas [GBMs] with IDH-wt, 5 GBMs with IDH-mut, 19 oligodendrogliomas [ODs], and 12 anaplastic oligodendrogliomas [AOs]) were included. All OD and AO patients had both IDH-mut and 1p/19q codeletion. The maximum standardized uptake value (SUV) of the tumor/mean SUV of normal cortex (T/N) ratios for MET, CHO, and FDG were calculated, and the mean T/N ratios of DA, AA, and GBM with IDH-wt and IDH-mut were compared. The diagnostic accuracy for distinguishing gliomas with IDH-wt from those with IDH-mut was assessed using receiver operating characteristic (ROC) curve analysis of the mean T/N ratios for the 3 PET tracers. RESULTS: There were significant differences in the mean T/N ratios for all 3 PET tracers between the IDH-wt and IDH-mut groups of all histological classifications (p < 0.001). Among the 27 gliomas with mean T/N ratios higher than the cutoff values for all 3 PET tracers, 23 (85.2%) were classified into the IDH-wt group using ROC analysis. In DA, there were no significant differences in the T/N ratios for MET, CHO, and FDG between the IDH-wt and IDH-mut groups. In AA, the mean T/N ratios of all 3 PET tracers in the IDH-wt group were significantly higher than those in the IDH-mut group (p < 0.01). In GBM, the mean T/N ratio in the IDH-wt group was significantly higher than that in the IDH-mut group for both MET (p = 0.034) and CHO (p = 0.01). However, there was no significant difference in the ratio for FDG. CONCLUSIONS: PET imaging using MET, CHO, and FDG was suggested to be informative for preoperatively differentiating gliomas according to the 2016 WHO classification, particularly for differentiating IDH-wt and IDH-mut tumors.
引用
收藏
页码:1010 / 1019
页数:10
相关论文
共 50 条
  • [1] World Health Organization 2016 Classification of Central Nervous System Tumors
    Diamandis, Phedias
    Aldape, Kenneth
    NEUROLOGIC CLINICS, 2018, 36 (03) : 439 - +
  • [2] Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
    Miyake, Keisuke
    Suzuki, Kenta
    Ogawa, Tomoya
    Ogawa, Daisuke
    Hatakeyama, Tetsuhiro
    Shinomiya, Aya
    Kudomi, Nobuyuki
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Tamiya, Takashi
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [3] Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016
    Malzkorn, Bastian
    Reifenberger, Guido
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (06) : 494 - 501
  • [4] Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification
    Ochirjav, Enkhee
    Enkhbat, Bayarmaa
    Baldandorj, Tuul
    Choe, Gheeyoung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2019, 53 (05) : 298 - 307
  • [5] Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics
    Colen, Rivka R.
    Hassan, Islam
    Elshafeey, Nabil
    Zinn, Pascal O.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2016, 24 (04) : 741 - 749
  • [6] Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system
    Jiang, Haihui
    Cui, Yong
    Wang, Junmei
    Lin, Song
    ONCOTARGET, 2017, 8 (12) : 20354 - 20361
  • [7] The 2021 World Health Organization Central Nervous System Tumor Classification: The Spectrum of Diffuse Gliomas
    Gue, Racine
    Lakhani, Dhairya A.
    BIOMEDICINES, 2024, 12 (06)
  • [8] Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
    Komori, Takashi
    LABORATORY INVESTIGATION, 2022, 102 (02) : 126 - 133
  • [9] Upstaging and Downstaging in Gliomas-Clinical Implications for the Fifth Edition of the World Health Organization Classification of Tumors of the Central Nervous System
    Trifanescu, Oana Gabriela
    Trifanescu, Raluca Alexandra
    Mitrica, Radu
    Mitrea, Dan
    Ciornei, Ana
    Georgescu, Mihai
    Butnariu, Ioana
    Gales, Laurentia Nicoleta
    Serbanescu, Luiza
    Anghel, Rodica Maricela
    Paun, Mihai-Andrei
    DIAGNOSTICS, 2023, 13 (02)